To evaluate the clinical efficacy of Tongxinluo Capsule（通心络胶囊）combined with atorvastatin calcium in the treatment of patients with angina pectoris of coronary heart disease with Qi deficiency and blood stasis.

A total of 302 patients with angina pectoris of coronary heart disease with Qi deficiency and blood stasis were selected and randomly divided into an observation group（152 cases）and a control group（150 cases）. The control group was treated with atorvastatin calcium tablets and the observation group was treated with Tongxinluo Capsule on the basis of the control group. Both groups were treated for 4 weeks. The clinical efficacy, the TCM symptom scores and angina attacks before and after treatment, cardiac enzyme parameters［creatine kinase-MB（CK-MB）, creatine kinase（CK）, lactate dehydrogenase（LDH）］, platelet aggregation rate, plasma viscosity, four hemorheological parameters of whole blood low shear and whole blood shear, interleukin-6（IL-6）, interleukin -18（IL-18）, C-reactive protein（CRP）, tumour necrosis factor-α（TNF-α）as well as adverse reactions that occurred during the study were observed.

After four weeks of treatment, the total effective rate of the observation group was 96.05%（146/152）, which was significantly higher than that of the control group（P < 0.05）. The symptom scores of the observation group were significantly reduced（P < 0.05）, the frequency, duration and dosage of angina pectoris were significantly reduced（P < 0.05）, the levels of CK-MB, CK and LDH were significantly reduced（P < 0.05）, the platelet aggregation rate, plasma viscosity, whole blood low shear and whole blood high shear parameters were also significantly reduced（P < 0.05）, the levels of IL-6, IL-18, CRP and TNF-α were also significantly reduced（P < 0.05）, and the improvement in the observation group was more obvious than that in the control group（P < 0.05）. In addition, both groups showed good safety during the research process.

Tongxinluo Capsule combined with atorvastatin calcium has a good clinical efficacy in the treatment of angina pectoris of coronary heart disease with Qi deficiency and blood stasis, can significantly improve the clinical symptoms and myocardial function, reduce the blood viscosity, weaken the body＇s inflammatory response, and has good safety.